Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 10,541,000 | 10,345,000 | 10,886,000 | 10,574,000 | 10,687,000 |
| Cost of Goods | 6,194,000 | 6,140,000 | 6,493,000 | 6,258,000 | 6,436,000 |
| Gross Profit | 4,347,000 | 4,205,000 | 4,393,000 | 4,316,000 | 4,251,000 |
| Operating Expenses | 2,527,000 | 2,543,000 | 2,539,000 | 2,452,000 | 2,673,000 |
| Operating Income | 1,820,000 | 1,663,000 | 1,854,000 | 1,864,000 | 1,578,000 |
| Interest Expense | 354,000 | 363,000 | 390,000 | 359,000 | 326,000 |
| Other Income | 215,000 | 312,000 | 275,000 | 243,000 | 162,000 |
| Pre-tax Income | 1,681,000 | 1,612,000 | 1,739,000 | 1,748,000 | 1,414,000 |
| Income Tax | 128,000 | 281,000 | 133,000 | 53,000 | 52,000 |
| Net Income Continuous | 1,553,000 | 1,331,000 | 1,606,000 | 1,695,000 | 1,362,000 |
| Minority Interests | 6,000 | 4,000 | -24,000 | -20,000 | 1,000 |
| Net Income | $1,547,000 | $1,327,000 | $1,630,000 | $1,715,000 | $1,361,000 |
| EPS Basic Total Ops | 4.05 | 3.47 | 4.21 | 4.44 | 3.53 |
| EPS Basic Continuous Ops | 4.07 | 3.48 | 4.16 | 4.39 | 3.53 |
| EPS Diluted Total Ops | 4.04 | 3.46 | 4.20 | 4.42 | 3.51 |
| EPS Diluted Continuous Ops | 4.05 | 3.47 | 4.14 | 4.37 | 3.51 |
| EPS Diluted Before Non-Recurring Items | 5.37 | 5.11 | 5.67 | N/A | N/A |
| EBITDA(a) | $2,611,000 | $2,498,000 | $2,693,000 | $2,717,000 | $2,433,000 |